Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Asheville, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Mountain Kidney Research
mi
from
Asheville, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Charlotte, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Metrolina Nephrology Assoc. PA
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Charlotte, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Sensenbrenner Primary Care
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Greenville, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Eastern Nephrology Associates
mi
from
Greenville, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Greenville, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
East Carolina University
mi
from
Greenville, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Kinston, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Eastern Nephrology Associates
mi
from
Kinston, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
New Bern, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Eastern Nephrology Associates, PLLC
mi
from
New Bern, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Rocky Mount, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Salisbury, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
W.G. (Bill) Hefner VAMC
mi
from
Salisbury, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Winston-Salem, NC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Brookview Hills Research Assoc
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Cincinnati, OH
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
VAMC Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Cincinnati, OH
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Cleveland, OH
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
MetroHealth Med Ctr
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Cleveland, OH
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Columbus, OH
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Endocrinology Associates Inc
mi
from
Columbus, OH
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Middleburg Heights, OH
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Clinical Research Solutions, LLC
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Oklahoma City, OK
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Harold Hamm Diabetes Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Portland, OR
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Bethlehem, PA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Northeast Clin Res Bethlehem
mi
from
Bethlehem, PA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Hershey, PA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Penn State University / Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Philadelphia, PA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Drexel Univ College of Med
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Philadelphia, PA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Philadelphia, PA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Philadelphia Health Associates
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Pittsburgh, PA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
VA Pittsburgh HealthcareSystem
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Pittsburgh, PA
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Pref Primary Care Phys Inc
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Providence, RI
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Columbia, SC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Columbia Nephrology Associates
mi
from
Columbia, SC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Columbia, SC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
WJB Dorn VA Medical Center
mi
from
Columbia, SC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Myrtle Beach, SC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Carolina Health Specialists
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Orangeburg, SC
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
SC Nephrology & Hypertension
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Chattanooga, TN
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Southeast Renal Research Inst
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Jackson, TN
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Advanced Kidney Specialists Pc
mi
from
Jackson, TN
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Knoxville, TN
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Knoxville Kidney Center PLLC
mi
from
Knoxville, TN
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Memphis, TN
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Univ TN Health Sciences Ctr
mi
from
Memphis, TN
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Corpus Christi, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Brusco, Corpus Christi, TX
mi
from
Corpus Christi, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Cypress, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Houston Nephrology Group
mi
from
Cypress, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Dallas, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Texas Health Physicians Group
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Dallas, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
North TX Endocrine Ctr
mi
from
Dallas, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Fort Worth, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Alvarado, Fort Worth, TX
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Houston, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Diagnostic Clinic of Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Houston, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Endocrine Associates
mi
from
Houston, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Houston, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Kidney and Hypertension Care
mi
from
Houston, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Houston, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
JM Research
mi
from
Houston, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Houston, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Primecare Medical Group
mi
from
Houston, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Houston, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Angiocardiac Care of Texas, PA
mi
from
Houston, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Lubbock, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
TX Tech Univ Health Science
mi
from
Lubbock, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Lufkin, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
East Texas Nephrology Assoc
mi
from
Lufkin, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
Lufkin, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
Texas Institute for Kidney & E
mi
from
Lufkin, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
McAllen, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
DCT - McAllen Primary Care Res
mi
from
McAllen, TX
Click here to add this to my saved trials
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated:  4/24/2018
mi
from
McAllen, TX
Study Of Diabetic Nephropathy With Atrasentan
A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan
Status: Enrolling
Updated: 4/24/2018
South Texas Kidney Specialists
mi
from
McAllen, TX
Click here to add this to my saved trials